The global Drug Development Testing Services market size was valued at US$ 654 million in 2024 and is forecast to a readjusted size of USD 1021 million by 2031 with a CAGR of 6.6% during review period.
Drug development can be divided into four phases: discovery, preclinical studies, clinical development and market approval.The Drug Discovery Process involves many different stages and series of actions. Lab-based drug tests are more accurate. We like to say they are more rigorous, more involved, and more defensible in a court of law, all of which are elements certain organizations must consider, particularly heavily regulated industries, like the DOT.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Drug Development Testing Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Drug Development Testing Services market size and forecasts, in consumption value ($ Million), 2020-2031
Global Drug Development Testing Services market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Drug Development Testing Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Drug Development Testing Services market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drug Development Testing Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drug Development Testing Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pacific BioLabs, Catalent, ICON, ProPharma Group, WuXi AppTec, Labcorp, MedPharm, Patheon, CTI, Thermo Fisher, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Drug Development Testing Services market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
In Vivo Services
Bio Chemistry Analytical
Microbiology Analytical
Others
Market segment by Application
Drug Development
Clinical Research
Others
Market segment by players, this report covers
Pacific BioLabs
Catalent
ICON
ProPharma Group
WuXi AppTec
Labcorp
MedPharm
Patheon
CTI
Thermo Fisher
ChemPartner
Frontage Labs
ChemDiv
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Drug Development Testing Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drug Development Testing Services, with revenue, gross margin, and global market share of Drug Development Testing Services from 2020 to 2025.
Chapter 3, the Drug Development Testing Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Drug Development Testing Services market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Development Testing Services.
Chapter 13, to describe Drug Development Testing Services research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Drug Development Testing Services by Type
1.3.1 Overview: Global Drug Development Testing Services Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Drug Development Testing Services Consumption Value Market Share by Type in 2024
1.3.3 In Vivo Services
1.3.4 Bio Chemistry Analytical
1.3.5 Microbiology Analytical
1.3.6 Others
1.4 Global Drug Development Testing Services Market by Application
1.4.1 Overview: Global Drug Development Testing Services Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Drug Development
1.4.3 Clinical Research
1.4.4 Others
1.5 Global Drug Development Testing Services Market Size & Forecast
1.6 Global Drug Development Testing Services Market Size and Forecast by Region
1.6.1 Global Drug Development Testing Services Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Drug Development Testing Services Market Size by Region, (2020-2031)
1.6.3 North America Drug Development Testing Services Market Size and Prospect (2020-2031)
1.6.4 Europe Drug Development Testing Services Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Drug Development Testing Services Market Size and Prospect (2020-2031)
1.6.6 South America Drug Development Testing Services Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Drug Development Testing Services Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 Pacific BioLabs
2.1.1 Pacific BioLabs Details
2.1.2 Pacific BioLabs Major Business
2.1.3 Pacific BioLabs Drug Development Testing Services Product and Solutions
2.1.4 Pacific BioLabs Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Pacific BioLabs Recent Developments and Future Plans
2.2 Catalent
2.2.1 Catalent Details
2.2.2 Catalent Major Business
2.2.3 Catalent Drug Development Testing Services Product and Solutions
2.2.4 Catalent Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Catalent Recent Developments and Future Plans
2.3 ICON
2.3.1 ICON Details
2.3.2 ICON Major Business
2.3.3 ICON Drug Development Testing Services Product and Solutions
2.3.4 ICON Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 ICON Recent Developments and Future Plans
2.4 ProPharma Group
2.4.1 ProPharma Group Details
2.4.2 ProPharma Group Major Business
2.4.3 ProPharma Group Drug Development Testing Services Product and Solutions
2.4.4 ProPharma Group Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 ProPharma Group Recent Developments and Future Plans
2.5 WuXi AppTec
2.5.1 WuXi AppTec Details
2.5.2 WuXi AppTec Major Business
2.5.3 WuXi AppTec Drug Development Testing Services Product and Solutions
2.5.4 WuXi AppTec Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 WuXi AppTec Recent Developments and Future Plans
2.6 Labcorp
2.6.1 Labcorp Details
2.6.2 Labcorp Major Business
2.6.3 Labcorp Drug Development Testing Services Product and Solutions
2.6.4 Labcorp Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Labcorp Recent Developments and Future Plans
2.7 MedPharm
2.7.1 MedPharm Details
2.7.2 MedPharm Major Business
2.7.3 MedPharm Drug Development Testing Services Product and Solutions
2.7.4 MedPharm Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 MedPharm Recent Developments and Future Plans
2.8 Patheon
2.8.1 Patheon Details
2.8.2 Patheon Major Business
2.8.3 Patheon Drug Development Testing Services Product and Solutions
2.8.4 Patheon Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Patheon Recent Developments and Future Plans
2.9 CTI
2.9.1 CTI Details
2.9.2 CTI Major Business
2.9.3 CTI Drug Development Testing Services Product and Solutions
2.9.4 CTI Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 CTI Recent Developments and Future Plans
2.10 Thermo Fisher
2.10.1 Thermo Fisher Details
2.10.2 Thermo Fisher Major Business
2.10.3 Thermo Fisher Drug Development Testing Services Product and Solutions
2.10.4 Thermo Fisher Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Thermo Fisher Recent Developments and Future Plans
2.11 ChemPartner
2.11.1 ChemPartner Details
2.11.2 ChemPartner Major Business
2.11.3 ChemPartner Drug Development Testing Services Product and Solutions
2.11.4 ChemPartner Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 ChemPartner Recent Developments and Future Plans
2.12 Frontage Labs
2.12.1 Frontage Labs Details
2.12.2 Frontage Labs Major Business
2.12.3 Frontage Labs Drug Development Testing Services Product and Solutions
2.12.4 Frontage Labs Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Frontage Labs Recent Developments and Future Plans
2.13 ChemDiv
2.13.1 ChemDiv Details
2.13.2 ChemDiv Major Business
2.13.3 ChemDiv Drug Development Testing Services Product and Solutions
2.13.4 ChemDiv Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 ChemDiv Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Drug Development Testing Services Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Drug Development Testing Services by Company Revenue
3.2.2 Top 3 Drug Development Testing Services Players Market Share in 2024
3.2.3 Top 6 Drug Development Testing Services Players Market Share in 2024
3.3 Drug Development Testing Services Market: Overall Company Footprint Analysis
3.3.1 Drug Development Testing Services Market: Region Footprint
3.3.2 Drug Development Testing Services Market: Company Product Type Footprint
3.3.3 Drug Development Testing Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Drug Development Testing Services Consumption Value and Market Share by Type (2020-2025)
4.2 Global Drug Development Testing Services Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Drug Development Testing Services Consumption Value Market Share by Application (2020-2025)
5.2 Global Drug Development Testing Services Market Forecast by Application (2026-2031)
6 North America
6.1 North America Drug Development Testing Services Consumption Value by Type (2020-2031)
6.2 North America Drug Development Testing Services Market Size by Application (2020-2031)
6.3 North America Drug Development Testing Services Market Size by Country
6.3.1 North America Drug Development Testing Services Consumption Value by Country (2020-2031)
6.3.2 United States Drug Development Testing Services Market Size and Forecast (2020-2031)
6.3.3 Canada Drug Development Testing Services Market Size and Forecast (2020-2031)
6.3.4 Mexico Drug Development Testing Services Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Drug Development Testing Services Consumption Value by Type (2020-2031)
7.2 Europe Drug Development Testing Services Consumption Value by Application (2020-2031)
7.3 Europe Drug Development Testing Services Market Size by Country
7.3.1 Europe Drug Development Testing Services Consumption Value by Country (2020-2031)
7.3.2 Germany Drug Development Testing Services Market Size and Forecast (2020-2031)
7.3.3 France Drug Development Testing Services Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Drug Development Testing Services Market Size and Forecast (2020-2031)
7.3.5 Russia Drug Development Testing Services Market Size and Forecast (2020-2031)
7.3.6 Italy Drug Development Testing Services Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Drug Development Testing Services Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Drug Development Testing Services Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Drug Development Testing Services Market Size by Region
8.3.1 Asia-Pacific Drug Development Testing Services Consumption Value by Region (2020-2031)
8.3.2 China Drug Development Testing Services Market Size and Forecast (2020-2031)
8.3.3 Japan Drug Development Testing Services Market Size and Forecast (2020-2031)
8.3.4 South Korea Drug Development Testing Services Market Size and Forecast (2020-2031)
8.3.5 India Drug Development Testing Services Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Drug Development Testing Services Market Size and Forecast (2020-2031)
8.3.7 Australia Drug Development Testing Services Market Size and Forecast (2020-2031)
9 South America
9.1 South America Drug Development Testing Services Consumption Value by Type (2020-2031)
9.2 South America Drug Development Testing Services Consumption Value by Application (2020-2031)
9.3 South America Drug Development Testing Services Market Size by Country
9.3.1 South America Drug Development Testing Services Consumption Value by Country (2020-2031)
9.3.2 Brazil Drug Development Testing Services Market Size and Forecast (2020-2031)
9.3.3 Argentina Drug Development Testing Services Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Drug Development Testing Services Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Drug Development Testing Services Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Drug Development Testing Services Market Size by Country
10.3.1 Middle East & Africa Drug Development Testing Services Consumption Value by Country (2020-2031)
10.3.2 Turkey Drug Development Testing Services Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Drug Development Testing Services Market Size and Forecast (2020-2031)
10.3.4 UAE Drug Development Testing Services Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Drug Development Testing Services Market Drivers
11.2 Drug Development Testing Services Market Restraints
11.3 Drug Development Testing Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Drug Development Testing Services Industry Chain
12.2 Drug Development Testing Services Upstream Analysis
12.3 Drug Development Testing Services Midstream Analysis
12.4 Drug Development Testing Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Pacific BioLabs
Catalent
ICON
ProPharma Group
WuXi AppTec
Labcorp
MedPharm
Patheon
CTI
Thermo Fisher
ChemPartner
Frontage Labs
ChemDiv
听
听
*If Applicable.
